Elevated Ratio of Maternal Plasma ApoCIII to ApoCII in Preeclampsia

Reproductive Sciences

Volumn 18, Issue 5, 2011, Pages 493-502

  Flood Nichols, Shannon K ^a   Gotkin, Jennifer L ^a   Napolitano, Peter G ^a   Stallings, Jonathan D ^a   Tinnemore, Deborah ^a   Ippolito, Danielle L ^a  

^a Madigan Healthcare System Joint Base Lewis McChord   (United States)

Author keywords

apolipoprotein C; glycosylation; preeclampsia; triglyceride

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; CELL CULTURE; CELL STRAIN U937; COHORT ANALYSIS; FEMALE; HUMAN; NEWBORN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; BIOLOGICAL MARKERS; CELLS, CULTURED; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; U937 CELLS; YOUNG ADULT;

EID: 84861098807     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110390390     Document Type: Review

References (27)

1. Widmer M. Villar J. Benigni A. Conde-Agudelo A. Karumanchi S.A. Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol. 2007; 109 (1): 168 - 180.
2. Roberts J. Preeclampsia a two-stage disorder: what is the linkage? Are there directed fetal/placental signals? In: Lyall F Belfort M eds. Preeclampsia: Etiology and Clinical Practice. Cambridge, UK: Cambridge University Press; 2007: 183 - 194.
3. Hubel C. Dyslipidemia and preeclampsia. In: Lyall F Belfort M (Eds.), Preeclampsia: Etiology and Clinical Practice. 2007; Cambridge, UK: Cambridge University Press, 164 - 178.
4. Noori M. Savvidou M. Williams D. Endothelial factors. In: Lyall F Belfort M, eds. Preeclampsia: Etiology and Clinical Practice. Cambridge, UK: Cambridge University Press; 2007: 50 - 78.
5. Pijnenborg R. Vercruysse L. Hanssens M. Van Assche F.A. Trophoblast invasion in preeclampsia and other pregnancy disorders. In: Lyall F Belfort M, eds. Preeclampsia: Etiology and Clinical Practice. Cambridge, UK: Cambridge University Press; 2007: 1 - 19.
6. Kawakami A. Aikawa M. Libby P. Alcaide P. Luscinskas F.W. Sacks F.M. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation. 2006; 113 (5): 691 - 700.
7. Wang C.S. Hartsuck J.A. Weiser D. Kinetics of acylglycerol hydrolysis by human milk lipoprotein lipase. Biochim Biophys Acta. 1985; 837 (2): 111 - 118.
8. Chan D.C. Chen M.M. Ooi E.M. Watts G.F. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?. Int J Clin Pract. 2008; 62 (5): 799 - 809.
9. Kawakami A. Osaka M. Aikawa M. et al. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ Res. 2008; 103 (12): 1402 - 1409.
10. Bondarenko P.V. Cockrill S.L. Watkins L.K. Cruzado I.D. Macfarlane R.D. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. J Lipid Res. 1999; 40 (3): 543 - 555.
11. Harvey S.B. Zhang Y. Wilson-Grady J. et al. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res. 2009; 8 (2): 603 - 612.
12. Mazurkiewicz J.C. Watts G.F. Warburton F.G. Slavin B.M. Lowy C. Koukkou E. Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients. J Clin Pathol. 1994; 47 (8): 728 - 731.
13. Bai H. Liu X. Liu R. Liu Y. Li M. Liu B. [Analysis of serum lipid and apolipoprotein levels in pregnancy-induced hypertension and normotensive pregnant women]. Hua Xi Yi Ke Da Xue Xue Bao. 2002; 33 (1): 58 - 61.
14. Chalas J. Audibert F. Francoual J. Le Bihan B. Frydman R. Lindenbaum A. Concentrations of apolipoproteins E, C2, and C3 and lipid profile in preeclampsia. Hypertens Pregnancy. 2002; 21 (3): 199 - 204.
15. Rasanen J. Girsen A. Reddy A. et al. Maternal serum biomarkers of gestational hypertension distinct from preeclampsia. Am J Obstet Gynecol. 2008; 199 (6 suppl A): S6.
16. American College of Obstetrics and Gynecology. ACOG Practice Bulletin Bariatric Surgery and Pregnancy. ACOG Practice Bulletin, June 2009. Obstet Gynecol. 2009; 113 (6): 1405 - 1413.
17. American College of Obstetrics and Gynecology. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin, January 2002. Obstet Gynecol. 2002; 99 (1): 159 - 167.
18. Ryu S. Huppmann A.R. Sambangi N. Takacs P. Kauma S.W. Increased leukocyte adhesion to vascular endothelium in preeclampsia is inhibited by antioxidants. Am J Obstet Gynecol. 2007; 196 (4): 400e1-400e7; discussion e7 - e8.
19. Burtis C. Ashwood E.R. Tietz N.W. In: Tietz Textbook of Clinical Chemistry. Philadelphia, PA: Saunders; 1999.
20. Cai S. Davis A.E. III. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol. 2003; 171 (9): 4786 - 4791.
21. Nelsestuen G.L. Zhang Y. Martinez M.B. et al. Plasma protein profiling: unique and stable features of individuals. Proteomics. 2005; 5 (15): 4012 - 4024.
22. Kawakami A. Yoshida M. Apolipoprotein CIII links dyslipidemia with atherosclerosis. J Atheroscler Thromb. 2009; 16 (1): 6 - 11.
23. Blumenstein M. McMaster M.T. Black M.A. et al. A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics. 2009; 9 (11): 2929 - 2945.
24. Huff M.W. Fidge N.H. Nestel P.J. Billington T. Watson B. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects. J Lipid Res. 1981; 22 (8): 1235 - 1246.
25. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol. 2001; 12 (3): 297 - 304.
26. Cohn J.S. Rodriguez C. Jacques H. Tremblay M. Davignon J. Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE. J Lipid Res. 2004; 45 (8): 1572 - 1579.
27. Ordovas J.M. Cassidy D.K. Civeira F. Bisgaier C.L. Schaefer E.J. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem. 1989; 264 (28): 16339 - 16342.